Since the combination of trimethoprim and sulphamethoxazole (cotrimoxazole) was introduced about four years ago, many reports have shown it to be effective against a variety of bacteria, except Pseudomonas aeruginosa. The initial low numbers of bacteria resistant to both its components gave considerable hope for a long therapeutic future for cotrimoxazole, particularly as resistance to sulphamethoxazole alone does not necessarily impair the synergism between the two drugs in vitro (Bushby, 1969) . However, in the last year there have been some reports of organisms resistant to both components of cotrimoxazole. Amongst coliforms, Lacey, Gillespie, Bruten, and Lewis (1972) found that about 2-5 % were resistant to trimethoprim, most also being resistant to sulphamethoxazole. In Streptococcus faecalis, resistance to trimethoprim appears to develop after exposure of the organism to cotrimoxazole in vivo (Chattopadhyay, 1972) . In strains of Staphylococcus aureus isolated from hospital sources about 1 -6 % are now resistant to both trimethoprim and sulphonamides,with 18 5 %resistant to sulphonamides alone (Nakhla, 1972) . Previously no trimethoprim resistance has been reported in this organism. The overall picture, therefore, is of a small but significant increase in bacteria resistant to cotrimoxazole.
In 1971 R factors producing resistance to both Received for publication 22 January 1973. trimethoprim and sulphonamides were detected in coliforms isolated from a few London hospitals (Fleming, Datta, and Gruneberg, 1972) ; Datta and Hedges (1972) have anticipated a dissemination of this R factor to other hospitals and throughout the coliform population generally. We have been monitoring coliforms isolated in Bristol for the last 18 months for the appearance of such an R factor and have found none. We also report some laboratory studies on the resistance to trimethoprim and sulphamethoxazole which might relate to the usefulness of this combination in the future. (Lacey et al, 1972) On strains giving absent or reduced zones, minimum inhibitory concentrations (MICs) were determined by the plate dilution method. Inocula were standardized to give about 2.0 colonies in 0-01 ml broth per test organism. Known sensitive and resistant strains were included in each batch. The endpoint was taken as that concentration ofeither a single drug or combination that prevented any visible growth after 20 hours' incubation at 37°C. For the determination of MBCs, trimethoprim and sulphamethoxazole were added to Harper Cawston broth the day before inoculation and stored at 4°C. Ten ml volumes of the broth were then inoculated with about 10r organisms suspended in 0-1 ml broth. After incubation for 24 hr at 37°C the broths were subcultured into solid medium. The MBC was defined as the concentration of cotrimoxazole that destroyed > 99 % of the inoculum. In estimating MICs the MBCs of mixtures of trimethoprim and sulphamethoxazole, the ratio of trimethoprim/sulphamethoxazole was 1:20, and generally increased in twofold concentrations.
Materials and Methods

ORGANISMS
ATTEMPTS AT TRANSFER OF ANTIBIOTIC RESISTANCE IN COLIFORMS
The method was essentially that of Moorhouse and McKay (1968) using mutants of E. coli K12 resistant to either rifampicin (100 ,ug/ml) or nalidixic acid (50 ,ug/ml) as recipient. Controls included a strain known to transfer tetracycline resistance to this and other recipients. Concentrations of trimethoprim used to detect possible transfer of resistance were 0-5, 1-0, and 5*0 ,kg/ml. For several organisms all three levels were used. In some experiments, other recipients were used; these were rifampicin-resistant mutants of strains recently isolated from different sources.
ATTEMPTS TO DEMONSTRATE LOSS OF TRIMETHOPRIM RESISTANCE IN S. A UREUS AND MUTAGENESIS OF CULTURES
Cultures were grown overnight at 420C, diluted, and inoculated into nutrient agar plates to give discrete colonies. These were then replicated onto nutrient agar containing 5% (v/v) lysed blood and 5 ,ug trimethoprim per ml. The method of mutagenesis of cultures of S. aureus and E. coli J53 (Su, Tp) has been previously described (Lacey, 1971) .
TRANSDUCTION OF TRIMETHOPRIM RESISTANCE IN S. AUREUS STRAIN NO. TPR-A
Cultures of the trimethoprim-resistant culture no. TPR-A were induced with mitomycin C. The resultant lysates were checked for sterility, and then irradiated with ultraviolet (UV) light for intervals of up to 5 min and added to the recipient strain 6936 (for further details see Lacey, 1971) . The recipient was then plated on nutrient agar containing 5% (v/v) lysed blood and 5 Kg trimethoprim/ml. After incubation, trimethoprim-resistant colonies were examined for sulphonamide resistance by replica plating onto media containing 500,ug sulphamethoxazole/ml.
DEVELOPMENT OF RESISTANCE TO TRIMETHOPRIM BY STRAINS OF E. COLI, STREP. FAEC.ALIS, AND S. AUREUS IN VITRO
After assessing the numbers of bacteria by the Miles and Misra method, the test organisms, either from centrifuged broth cultures or directly from plate cultures, were inoculated onto DST agar containing 5 % lysed blood and various levels of trimethoprim. The inoculated plates were incubated for 48 hours at 37°C for E. coli and S. aureus and 96 hours at 37°C for Strep. faecalis.
Trimethoprim lactate and sulphamethoxazole were obtained from Burroughs Wellcome Ltd, Beckenham, Kent.
Results
TRIMETHOPRIM RESISTANCE IN COLIFORMS
From November 1971 to October 1972, a total of 711 strains of coliforms from hospital and non-hospital patients were tested for resistance to trimethoprim by the disk method. All coliform strains were tested during three one-month periods; at other times strains were tested when it was clinically relevant. Of these strains, 16 (2-3 %) were resistant to between 2 and 100,ug trimethoprim/ml. Further identification of these organisms showed that three were atypical Klebsiella, four Enterobacter species, and nine Escherichia. Since no property investigated was associated with a particular species, this group of organisms is referred to as coliforms. A similar incidence (2-5 %) was found in the strains isolated earlier in 1971 (Lacey et al, 1972) . Of the 16 strains isolated since November 1971, 13 were also resistant to sulphamethoxazole (MIC >4000 ,ug/ml). The sensitivity to cotrimoxazole varied from an MIC of 0-2 ,ug trimethoprim and 4 ,ug sulphamethoxazole/ ml to > 25-6 ,ug trimethoprim and 512 ,ug sulphamethoxazole/ml. Most Darrell, Garrod, and Waterworth (1968) and Bushby (1969) (Nakhla, 1972 Since both trimethoprim and sulphamethoxazole act on the same biosynthetic pathway (Hitchings, 1969) , it is theoretically possible that a single biochemical mechanism can produce resistance to both drugs simultaneously, in which case the same gene(s) will determine both resistances. We have found that sulphonamide resistance in some coliforms may be transferred to E. coli K12 without trimethoprim resistance (Lacey et al, 1972) . In these organisms the genes determining each resistance must be distinct. The question whether these genes were also different was investigated in a strain of E. coli harbouring an R factor conferring resistance to both drugs (J53 (Su, Tp) ) and in two cultures of S. aureus. Cultures were treated with a mutagen (nitrosoguanidine) and examined for loss of trimethoprim resistance by replica plating. About 0-1 % colonies of each strain became trimethoprim sensitive (table III) . Although some of these were also sulphonamide sensitive, at least one colony fully sensitive to trimethoprim (MIC 0'1 ,ug/ml) and resistant to sulphamethoxazole (MIC > 500 ,g/ml) was obtained from each strain. The mutants resembled the wild strains in other properties. Thus the gene(s) coding for resistance to the two drugs are distinct in the three strains. It is interesting to note that whenever trimethoprim resistance was lost, the MIC of the culture to cotrimoxazole became sensitive regardless of the level of resistance to sulphonamide (table III) .
CHROMOSOMAL LOCUS OF GENES DETERMINING TRIMETHOPRIM RESISTANCE IN S. A UREUS
Because staphylococcal plasmids may be lost after growth at 43°C (eg, May, Houghton, and Perrett, 1964) , strain nos. TPR-A, TPR-B, and TPR-C were grown overnight at 430 and then examined for loss of trimethoprim resistance by replica plating. No loss of resistance was found amongst 22000 colonies of strain no. TPR-A, 5000 of TPR-B, and 9500 of TPR-C. The stability of the resistance after growth at 43°C suggested a chromosomal locus for the genes in question. This was confirmed in strain no.
TPR-A by transduction. Cultures of strain no. TPR-A were induced with mitomycin C and the resultant lysate irradiated with ultraviolet light for various intervals and then added to the recipient (strain 6936). The transduction frequency from the unirradiated lysate was low (2 x 10-9) but after ultraviolet irradiation the frequency rose to a maximum of 3-2 x 10-6 (table IV) . Such stimulation of the frequency is indicative of chromosomal genes (Arber, 1960; Asheshov, 1966) . and 240 ,ug sulphamethoxazole/ml). Since many coliforms and staphylococci are resistant to sulphonamides, the usefulness of cotrimoxazole against these organisms depends on the absence of trimethoprim resistance in sulphonamide-resistant cells. There is no evidence for a single mechanism that confers resistance to both drugs simultaneously; even in a strain of E. coli in which an R factor gives high-level resistance to both drugs, the genes are distinct. Mutation to trimethoprim resistance in sulphonamide-resistant strains of E. coli and S. aureus is unlikely to be important under natural conditions. We have been unable to obtain one-step mutants resistant to moderate levels of trimethoprim which are not grossly defective. Although it is possible for resistance to develop by serial transfer in the presence of the drug, there is no evidence that this process occurs in vivo.
None of the coliform isolates could transfer trimethoprim resistance in vitro. Information on the 'epidemiology' of R factors under natural conditions is scanty, although much is known about their properties in vitro. The possibility that R factors determining high-level resistance to trimethoprim and sulphonamides will spread through the enterobacteriaceae as suggested by Datta and Hedges(1972) remains a threat, but has not happened yet, at least in Bristol. The resistance to trimethoprim in these coliforms and staphylococci is probably intrinsic, present in a minority of strains. The incidence of these resistant isolates may be expected to increaseprobably slowly-with the use of cotrimoxazole. The three trimethoprim-resistant strains of S. aureus described here are very similar in properties to those described by Nakhla (1972) . All could have evolved from a single clone. The gene(s) determining trimethoprim resistance is chromosomal in strain no. TPR-A and probably also in strains TPR-B and TPR-C. If the genetic locus for trimethoprim resistance in all staphylococci is chromosomal, this might explain why trimethoprim resistance has not 'spread' to other staphylococci. Chromosomal genes are transferred between cultures of S. aureus at much lower frequencies than plasmid genes (Lacey, 1972a) . Fortunately trimethoprim-resistant strains are sensitive to methicillin; methicillin resistance is unlikely to be transferred to other strains (Lacey, 1972b) . Based on these findings in vitro, strains of S. aureus should be expected to retain their sensitivity to either cotrimoxazole or methicillin for some time to come. In contrast, the value of cotrimoxazole in treating infections due to Strep. faecalis seems limited. Chattopadhyay (1972) showed that strains of Strep. faecalis developed resistance to cotrimoxazole during therapy with this drug; the reason for this would seem to be the frequent occurrence of mutants of Strep. faecalis which possess resistance to trimethoprim.
